Treating Menière’s disease with rimegepant

Treating Menière’s disease with rimegepant

A recent hypothesis states that Menière’s disease is caused by inappropriate expression, i.e. enhanced release of the neurotransmitter calcitonin gene-related peptide. Here, we tested this hypothesis by administering rimegepant, a new calcitonin gene-related peptide antagonist approved for the acut...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefan C. A. Hegemann, Angela Schell
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2025-02-01
Series:Swiss Medical Weekly
Online Access:https://smw.ch/index.php/smw/article/view/4147
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items